Molina Healthcare (MOH) EVP gets stock grant and tax withholding

Rhea-AI Filing Summary

Molina Healthcare executive Debra Bacon reported equity compensation activity and related tax withholding. On March 1, 2026, 716 shares of common stock at $154.05 per share were withheld and disposed of to cover taxes tied to the vesting of 2,021 shares. The price reflects the closing price on February 27, 2026.

On the same date, Bacon received a grant of 9,606 restricted shares of Molina Healthcare common stock under the company’s 2025 Equity Incentive Plan at a reference price of $145.75, based on a 10-day volume-weighted average price. These 9,606 shares vest in three equal installments on March 1 of 2027, 2028, and 2029, with additional previously granted shares scheduled to vest on July 1, 2026 and March 1, 2027 and 2028. After these transactions, she directly held 21,796 common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bacon Debra

(Last) (First) (Middle)

2180 HARVARD STREET, SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Medicaid

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		716(1)	D	$154.05(2)	12,190	D
Common Stock	03/01/2026		A		9,606(3)	A	$145.75(4)	21,796(5)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were applied to the payment of withholding taxes arising in connection with the vesting of 2,021 shares on March 1, 2026.

2. Represents the closing price of the Issuer's common stock on February 27, 2026.

3. Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.

4. Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.

5. The shares shall vest as follows: The 9,606 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 on March 1, 2028. The remaining shares are vested.

Remarks:

	Jeff D. Barlow, by power of attorney for Debra Bacon	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Molina Healthcare (MOH) executive Debra Bacon report in this Form 4?

Debra Bacon reported a tax-withholding share disposition and a new restricted stock grant. Shares were withheld to pay taxes on vesting stock, while 9,606 new restricted shares were granted under Molina Healthcare’s 2025 Equity Incentive Plan with future vesting dates.

How many Molina Healthcare shares were disposed of for tax withholding by Debra Bacon?

Debra Bacon had 716 Molina Healthcare common shares disposed of to cover tax withholding. The shares related to the vesting of 2,021 shares on March 1, 2026 and were valued at the February 27, 2026 closing price of $154.05 per share.

What stock grant did Molina Healthcare (MOH) EVP Debra Bacon receive?

Debra Bacon received a grant of 9,606 restricted shares of Molina Healthcare common stock. The grant was made under the 2025 Equity Incentive Plan at a reference price of $145.75, based on the 10-day volume-weighted average price before March 1, 2026.

What is the vesting schedule for Debra Bacon’s 9,606 newly granted Molina Healthcare shares?

The 9,606 newly granted restricted shares vest in three equal installments. One-third vests on March 1, 2027, another third on March 1, 2028, and the final third on March 1, 2029, subject to the conditions of Molina Healthcare’s 2025 Equity Incentive Plan.

Were there additional Molina Healthcare shares scheduled to vest for Debra Bacon?

Yes. Additional shares are scheduled to vest as follows: 529 shares on July 1, 2026, 1,775 shares on March 1, 2027, and 1,018 shares on March 1, 2028. The remaining reported shares were already vested according to the footnotes provided.

How many Molina Healthcare (MOH) shares did Debra Bacon hold after these transactions?

After the reported transactions, Debra Bacon directly held 21,796 shares of Molina Healthcare common stock. This figure reflects the impact of both the 716-share tax-withholding disposition and the 9,606-share restricted stock grant reported for March 1, 2026.